Literature DB >> 12810154

Polymorphisms in CYP-7A1, not APOE, influence the change in plasma lipids in response to population dietary change in an 8 year follow-up; results from the Czech MONICA study.

Jaroslav A Hubacek1, Jan Pitha, Zdena Skodová, Rudolf Poledne, Vera Lánská, Dawn M Waterworth, Steve E Humphries, Philippa J Talmud.   

Abstract

OBJECTIVES: To evaluate the influence of variation in the genes for apolipoprotein E (APOE; epsilon2, epsilon3, epsilon4) and cholesterol-7alpha hydroxylase (CYP-7A1; -204A-->C) on plasma lipid level changes. DESIGN AND METHODS: 131 males for whom dietary composition markedly changed and total cholesterol decreased (from 6.21 +/- 1.31 mmol/L in 1988 - 5.43 +/- 1.06 mmol/L in 1996) over an 8 yr follow-up study. Polymorphisms were investigated using PCR.
RESULTS: APOE genotype influenced plasma total and LDL cholesterol, with carriers of the epsilon4 having the highest and epsilon2 carriers the lowest levels, this reached borderline significance for cholesterol in 1988 (p = 0.06) and strongly affected the 1996 levels of LDL cholesterol (p = 0.008). However, APOE did not influence the change in these measures over time. In contrast, the CYP-7A1 -204A-->C polymorphism did not affect lipid measures per se but was strongly associated with a decrease in plasma total cholesterol [AA -0.38 (+/- 0.20) mmol/L, AC -0.65 +/- (0.08), CC -1.33 (+/- 0.3) mmol/L, p = 0.01] over the 8 yr time period.
CONCLUSIONS: Variation in the CYP-7A1 gene may play an important role in an individual's sensitivity to dietary composition.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12810154     DOI: 10.1016/s0009-9120(03)00025-0

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  5 in total

1.  Pharmacogenetic determinants of variability in lipid-lowering response to pravastatin therapy.

Authors:  Hiroshi Takane; Masanori Miyata; Naoto Burioka; Chiaki Shigemasa; Eiji Shimizu; Kenji Otsubo; Ichiro Ieiri
Journal:  J Hum Genet       Date:  2006-08-18       Impact factor: 3.172

Review 2.  Role of cholesterol 7alpha-hydroxylase (CYP7A1) in nutrigenetics and pharmacogenetics of cholesterol lowering.

Authors:  Jaroslav A Hubacek; Dagmar Bobkova
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

3.  Linkage disequilibrium blocks, haplotype structure, and htSNPs of human CYP7A1 gene.

Authors:  Kaori Nakamoto; Shuang Wang; Robert D Jenison; Grace L Guo; Curtis D Klaassen; Yu-Jui Yvonne Wan; Xiao-bo Zhong
Journal:  BMC Genet       Date:  2006-05-18       Impact factor: 2.797

4.  Relationship between CYP7A1 -204A>C polymorphism with gallbladder stone disease and serum lipid levels: a meta-analysis.

Authors:  Qiang Cai; Zhen-Qiang Wang; Qu Cai; Chen Li; Er-Zhen Chen; Zhao-Yan Jiang
Journal:  Lipids Health Dis       Date:  2014-08-08       Impact factor: 3.876

5.  Diurnal variation in cholesterol 7α-hydroxylase activity is determined by the -203A>C polymorphism of the CYP7A1 gene.

Authors:  Miluše Vlachova; Tereza Blahova; Vera Lanska; Martin Leníček; Jan Pitha; Libor Vítek; Jan Kovar
Journal:  Croat Med J       Date:  2016-04-23       Impact factor: 1.351

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.